| Code | 02726 | ||||||||||
| MA number | EU/1/98/063/011 | ||||||||||
| Product Form: | sol inj 1x0,5 ml/22 µg (pero napln.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Merck Europe B.V., Netherland | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 18 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 02.06.2010 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC interferóny final 25 8 2014.pdf
|
| Safety feature | Yes |
| Data update: | 19.06.2018 |
